CompletedNot applicableNCT06064851
Delivering Transcutaneous Auricular Neurostimulation to Reduce Heavy Menstrual Bleeding in Patients With and Without Von Willebrand Disease
Studying Von Willebrand disease type 1
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Five Liters, Inc.
- Principal Investigator
- Navid Khodaparast, PhDChief Science Officer
- Intervention
- Volta System(device)
- Enrollment
- 29 enrolled
- Eligibility
- 18-45 years · FEMALE
- Timeline
- 2023 – 2025
Study locations (1)
- Five Liters, Dallas, Texas, United States
Collaborators
Spark Biomedical, Inc.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06064851 on ClinicalTrials.gov